VDR and inflammatory bowel disease: The limitations of this pilot study mainly include the small cohort of IBD patients, the unknown VDR genotype, and the lack of follow-up for patients who tested negative for SARS-CoV-2 IgGs to determine if they were actually infected with the virus and to assess the clinical outcomes following Vit.D supplementation.